Please login to the form below

NovoSeven

This page shows the latest NovoSeven news and features for those working in and with pharma, biotech and healthcare.

EMA clears Novo Nordisk’s long-acting haemophilia A drug

That is a positive for Novo Nordisk’s overall haemophilia franchise which is being hit by declining sales of factor VII replacement product NovoSeven, but there’s little doubt that the

Latest news

First blood to Roche in Hemlibra patent fight with Shire

The haemophilia A with inhibitors category is currently dominated by Shire and Novo Nordisk with its Feiba and NovoSeven bypassing agents (PBAs).
Roche gets first approval for haemophilia A therapy

The market for haemophilia A with inhibitors is currently dominated by Shire and Novo Nordisk with their Feiba and NovoSeven bypassing agents (PBAs).
Shire wins block of Roche' 'misinformation' over emicizumab

The market for haemophilia A with inhibitors is currently dominated by Shire and Novo Nordisk with their Feiba and NovoSeven bypassing agents (PBAs).
Patient death mars Roche haemophilia drug trial

for breakthrough bleeds which includes Shire's Feiba and Novo Nordisk's NovoSeven. ... Analysts have previously suggested that emicizumab could attack around half the revenues of NovoSeven, which made sales of almost $1.4bn in 2016, and eat into the
Novo Nordisk wins US approval for haemophilia treatment

The drug will be used in conjunction with Novo's MixPro, the pre-filled device that was launched earlier this year and is already in use with the company's NovoSeven ... Novo's existing haemophilia A and B treatment for patients with inhibitors, NovoSeven

More from news
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest Intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’

His confidence is underpinned by more launches being inked into the Biopharm calendar, along with recent European approval for a bolus delivery system for its NovoSeven haemophilia product. ... For years physicians were asking us for NovoSeven to be used

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Senior Content Editor - Biotechnology: Salary TBC

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Principal Medical Writer: Varies on experience

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Account Management: Competitive Salary Offered

PMHub

Add my company

Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

WHITE PAPER: Why do men die younger?: It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials: Here are some useful tips to help get your hands on authentically diverse stock photos....
Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...